The role of imaging in staging and monitoring testicular cancer - 17/04/12

Doi : 10.1016/j.diii.2012.01.014

L. Brunereau ^a,^⁎ , F. Bruyère ^b, C. Linassier ^c, J.-L. Baulieu ^d
^a UFR médecine, Departement of Diagnostic and Interventional Radiology-Neuroradiology, Center for Medical Imaging, CHU de Tours, université François-Rabelais, 37044 Tours cedex 9, France
^b UFR médecine, Department of Urology, CHU de Tours, université François-Rabelais, 37044 Tours cedex 9, France
^c UFR médecine, Department of Medical Oncology, CHU de Tours, université François-Rabelais, 37044 Tours, France
^d UFR médecine, Department of Nuclear Medicine, CHU de Tours, université François-Rabelais, 37044 Tours, France

Corresponding author.

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

The prognosis for testicular cancer is excellent, with a 5-year survival rate greater than 95%. Patients affected can therefore expect to be cured after treatment. Successful treatment requires assessment of the condition at the various stages of its management. Imaging plays a major role in initial analysis of the lymphatic extension and in looking for metastases. It is essential for evaluating the response to treatment and during follow-up after treatment. CT is the most commonly used imaging method in this context, but the role of PET is currently developing. The purpose of this paper is to review the role of the imaging methods commonly used in the management of testicular cancer.

Le texte complet de cet article est disponible en PDF.

Keywords : Testis and appendices, Cancer, Oncology, Scanning techniques